Cell in Cells
Seoul
About Cell in Cells
Cell in Cells researches and develops cell therapy products for regenerative medicine through the 3D technology of stem cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2021)
- Website: cellincells.com
- Phone: +82 02 740 8641
Industries & Categories
3D Technology, Biotechnology, Medical
Canonical: https://fsome.com/organization/cell-in-cells-109725 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.